Cited by 815Ovarian function and disordersHormonal and reproductive studiesDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

A Direct Effect of Hyperinsulinemia on Serum Sex Hormone-Binding Globulin Levels in Obese Women with the Polycystic Ovary Syndrome*

NESTLER, JOHN E., POWERS, LINDA P., MATT, DENNIS W., STEINGOLD, KENNETH A., PLYMATE, STEPHEN R., RITTMASTER, ROGER S., CLORE, JOHN N., BLACKARD, WILLIAM G.·1991·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jcem-72-1-83

Open this paper in CoChat — free account

Abstract

To determine whether hyperinsulinemia can directly reduce serum sex hormone-binding globulin (SHBG) levels in obese women with the polycystic ovary syndrome, six obese women with this disorder were studied. Before study, ovarian steroid production was suppressed in each woman by the administration of 7.5 mg of a long-acting GnRH agonist, leuprolide depot, im, on days -56, -28, and 0. This resulted in substantial reductions in serum concentrations of testosterone (from 1.72 +/- 0.29 nmol/L on day -56 to 0.32 +/- 0.09 nmol/L on day 0), non-SHBG-bound testosterone (from 104 +/- 16 pmol/L on day -56 to 19 +/- 5 pmol/L on day 0), androstenedione (from 7.25 +/- 1.65 nmol/L on day -56 to 2.78 +/- 0.94 nmol/L on day 0), estrone (from 371 +/- 71 pmol/L on day -56 to 156 +/- 29 pmol/L on day 0), estradiol (from 235 +/- 26 pmol/L on day -56 to 90 +/- 24 pmol/L on day 0), and progesterone (from 0.28 +/- 0.12 nmol/L on day -56 to 0.08 +/- 0.02 nmol/L on day 0). Serum SHBG levels, however, did not change (18.8 +/- 2.8 nmol/L on day -56 vs. 17.8 +/- 2.6 nmol/L on day 0). While continuing leuprolide treatment, the women were administered oral diazoxide (300 mg/day) for 10 days to suppress serum insulin levels. Diazoxide treatment resulted in suppressed insulin release during a 100-g oral glucose tolerance test (insulin area under the curve, 262 +/- 55 nmol/min.L on day 0 vs. 102 +/- 33 nmol/min.L on day 10; P less than 0.05) and deterioration of glucose tolerance. Serum testosterone, androstenedione, estrone, estradiol, and progesterone levels did not change during combined diazoxide and leuprolide treatment. In contrast, serum SHBG levels rose by 32% from 17.8 +/- 2.6 nmol/L on day 0 to 23.5 +/- 2.0 nmol/L on day 10 (P less than 0.003). Due primarily to the rise in serum SHBG levels, serum non-SHBG-bound testosterone levels fell by 43% from 19 +/- 5 pmol/L on day 0 to 11 +/- 4 pmol/L on day 10 (P = 0.05). These observations suggest that hyperinsulinemia directly reduces serum SHBG levels in obese women with the polycystic ovary syndrome independently of any effect on serum sex steroids.

Integrity signals

Registry

Crossref · 10.1210/jcem-72-1-83

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats
Morgan, C. R., & Lazarow, A. (1963) · Diabetes · doi:10.2337/diab.12.2.115 · Cited by 2,197
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*
Burghen, G. A., Givens, J. R., & Kitabchi, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-113 · Cited by 919
Insulin resistance in nonobese patients with polycystic ovarian disease
CHANG, R. J., NAKAMURA, R. M., JUDD, H. L., & KAPLAN, S. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-356 · Cited by 704
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin.
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
Self-citation
Insulin Stimulates Androgen Accumulation in Incubations of Ovarian Stroma Obtained from Women with Hyperandrogenism*
Barbieri, R. L., Makris, A., Randall, R. W., Daniels, G. H., Kistner, R. W., & Ryan, K. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-904 · Cited by 629
Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.
NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
Self-citation
Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: An analysis of 263 consecutive cases
KIDDY, D. S., SHARP, P. S., WHITE, D. M., SCANLON, M. F., MASON, H. D., BRAY, C. S., POLSON, D. W., REED, M. J., & FRANKS, S. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00857.x · Cited by 364
Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease
DeVane, G. W., Czekala, N. M., Judd, H. L., & Yen, S. S. C. (1975) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(75)90081-2 · Cited by 338

Flagged first, then by citations

Show all 38 references

Sorted by citations

Items 301–400 of 814

Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome
Bıdecı, A., Çamurdan, M. O., Yeşilkaya, E., Demirel, F., & Cınaz, P. (2008) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2008.00819.x · Cited by 41
Statins in the Treatment of Polycystic Ovary Syndrome
Kodaman, P. H., & Dulęba, A. J. (2008) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-992933 · Cited by 43
Polycystic Ovary Syndrome and Insulin: Our Understanding in the Past, Present and Future
Mayer, S., Evans, W. S., & Nestler, J. E. (2015) · Women s Health · doi:10.2217/whe.14.73 · Cited by 46
Self-citation
Polycystic Ovary Syndrome
Sood, M., Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_33 · Cited by 43
The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis
Mor, E., Zograbyan, A., Saadat, P., Bayrak, A., Tourgeman, D. E., Zhang, C., Stanczyk, F. Z., & Paulson, R. J. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.02.052 · Cited by 44
Puberty and Its Disorders in the Female
Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50019-3 · Cited by 44
Determinants of sex hormone‐binding globulin in normal postmenopausal women
Wu, F., Ames, R. W., Evans, M. C., France, J. T., & Reid, I. R. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01183.x · Cited by 43
Pathophysiological Effects of Contemporary Lifestyle on Evolutionary-Conserved Survival Mechanisms in Polycystic Ovary Syndrome
Parker, J. (2023) · Life · doi:10.3390/life13041056 · Cited by 43
Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential
Yuan, J., Li, Z., Yu, Y., Wang, X., & Zhao, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1520695 · Cited by 42
The Effect of Galega officinalis on Hormonal and Metabolic Profile in a Rat Model of Polycystic Ovary Syndrome
Abtahi‐Eivary, S., Moghimian, M., Soltani, M., Shoorei, H., Asghari, R., Hajizadeh, H., Shokoohi, M., Alami, S., & Ghaderi, F. K. (2017) · International Journal of Women s Health and Reproduction Sciences · doi:10.15296/ijwhr.2018.46 · Cited by 42
Using genetics to decipher the link between type 2 diabetes and cancer: shared aetiology or downstream consequence?
Vincent, E. E., & Yaghootkar, H. (2020) · Diabetologia · doi:10.1007/s00125-020-05228-y · Cited by 42
Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance
Hernández-Jiménez, J. L., Barrera, D., Espinoza‐Simón, E., González, J., Ortiz-Hernández, R., Escobar, M. L., Echeverría, O. M., & Torres‐Ramírez, N. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.2003326 · Cited by 44
Cryptotanshinone Reverses Reproductive and Metabolic Disturbances in PCOS Model Rats via Regulating the Expression of CYP17 and AR
Yu, J., Zhai, D., Li, H., Zhang, D., Bai, L., Cai, Z., & Yu, C. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/670743 · Cited by 41
Clinical presentation of PCOS following development of an insulinoma: Case Report
Murray, R. D., Davison, R. M., Russell, R. C. G., & Conway, G. S. (2000) · Human Reproduction · doi:10.1093/humrep/15.1.86 · Cited by 41
Barriers and Facilitators to the Implementation of Evidence-Based Lifestyle Management in Polycystic Ovary Syndrome: A Narrative Review
Blackshaw, L. C. D., Chhour, I., Stepto, N. K., & Lim, S. S. (2019) · Medical Sciences · doi:10.3390/medsci7070076 · Cited by 40
[Genetic aspects of polycystic ovary syndrome].
Jakubowski, L. (2005) · PubMed · Cited by 40
Total and high–molecular weight adiponectin in women with the polycystic ovary syndrome
Wickham, E. P., Cheang, K. I., Clore, J. N., Baillargeon, J., & Nestler, J. E. (2010) · Metabolism · doi:10.1016/j.metabol.2010.02.019 · Cited by 40
Self-citation
Effects of resveratrol on ovarian response to controlled ovarian hyperstimulation in ob/ob mice
Cabello, E., Garrido, P., Morán, J., del Rey, C. G., Llaneza, P., Llaneza-Suárez, D., Alonso, A., & González, C. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.10.034 · Cited by 40
The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial
Jafari-Sfidvajani, S. J., Ahangari, R., Hozoori, M., Mozaffari–Khosravi, H., Fallahzadeh, H., & Nadjarzadeh, A. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0785-9 · Cited by 43
From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management
Pani, A., Gironi, I., Di Vieste, G., Mion, E., Bertuzzi, F., & Pintaudi, B. (2020) · International Journal of Endocrinology · doi:10.1155/2020/6276187 · Cited by 38
Hyperandrogenism in Women with Polycystic Ovarian Syndrome: Pathophysiology and Controversies
Kanbour, S., & Dobs, A. S. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0020 · Cited by 38
Menstrual Irregularities
Foster, C., & Al-Zubeidi, H. (2018) · Pediatric Annals · doi:10.3928/19382359-20171219-01 · Cited by 54
Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena
Rondanelli, M., Perna, S., Faliva, M. A., Monteferrario, F., Repaci, E., & Allieri, F. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3433-z · Cited by 44
Current and future status of ovulation induction in polycystic ovary syndrome
Messinis, I. E. (1997) · Human Reproduction Update · doi:10.1093/humupd/3.3.235 · Cited by 38
Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome
Alpañés, M., Luque‐Ramírez, M., Martínez-García, M. Á., Fernández‐Durán, E., Álvarez‐Blasco, F., & Escobar-Morreale, H. F. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.12.105 · Cited by 37
Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes?
Korytkowski, M. T., Krug, E. I., Daly, M. A., DeRiso, L., Wilson, J. W., & Winters, S. J. (2005) · Metabolism · doi:10.1016/j.metabol.2005.06.011 · Cited by 38
Genetic Basis of Metabolic Abnormalities in Polycystic Ovary Syndrome
Rold??n, B., n, J. L. S. M., & Escobar-Morreale, H. F. (2004) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200404020-00004 · Cited by 39
Metabolic Syndrome: Polycystic Ovary Syndrome.
Mortada, R. A., & Williams, T. (2015) · PubMed · Cited by 37
Polycystic Ovary Syndrome: Novel and Hub lncRNAs in the Insulin Resistance-Associated lncRNA–mRNA Network
Zhao, J., Huang, J., Geng, X., Chu, W., Li, S., Chen, Z., & Du, Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00772 · Cited by 37
RETRACTED: Effect of metformin pretreatment on pregnancy outcome of in vitro matured oocytes retrieved from women with polycystic ovary syndrome
Wei, Z., Cao, Y., Cong, L., Zhou, P., Zhang, Z., & Li, J. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.07.1385 · Cited by 37
Retracted
Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications
Taylor, A. E. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70239-x · Cited by 35
Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome
Glueck, C. J., Aregawi, D., Agloria, M., Winiarska, M., Sieve, L., & Wang, P. (2006) · Metabolism · doi:10.1016/j.metabol.2006.08.001 · Cited by 37
Interface between Extra‐ and Intraovarian Factors in Polycystic Ovarian Syndrome
YEN, S. S. C., LAUGHLIN, G. A., & MORALES, A. J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb43858.x · Cited by 36
Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome
Pawelczyk, L. A., Spaczyński, R., Banaszewska, B., & Dulęba, A. J. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2003.09.031 · Cited by 36
Regulation of Human Dehydroepiandrosterone Metabolism by Insulina
Nestler, J. E. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17373.x · Cited by 36
Self-citation
A Dietary Medium-Chain Fatty Acid, Decanoic Acid, Inhibits Recruitment of Nur77 to the HSD3B2 Promoter In Vitro and Reverses Endocrine and Metabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome
Lee, B. H., Indran, I. R., Tan, H. M., Li, Y., Zhang, Z., Li, J., & Yong, E. (2015) · Endocrinology · doi:10.1210/en.2015-1733 · Cited by 35
Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients
Ruan, X., Jing-hua, S., Gu, M., Wang, L., Wang, H., & Mueck, A. O. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4762-0 · Cited by 35
Menopausal Acne – Challenges And Solutions
Khunger, N., & Mehrotra, K. (2019) · International Journal of Women s Health · doi:10.2147/ijwh.s174292 · Cited by 35
The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women
Valderhaug, T. G., Hertel, J. K., Nordstrand, N., Dale, P. O., Hofsø, D., & Hjelmesaeth, J. S. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0040-5 · Cited by 35
Genetics of androgen metabolism in women with infertility and hypoandrogenism
Shohat-Tal, A., Sen, A., Barad, D. H., Kushnir, V. A., & Gleicher, N. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.64 · Cited by 37
Differential Effects of Raloxifene and Estrogen on Insulin Sensitivity in Postmenopausal Women
Lee, C. C., Kasa-Vubu, J. Z., & Supiano, M. A. (2003) · Journal of the American Geriatrics Society · doi:10.1034/j.1600-0579.2003.00214.x · Cited by 36
Association between Components of the Insulin-Like Growth Factor System and Epithelial Ovarian Cancer Risk
Maso, L. D., Augustin, L. S. A., Franceschi, S., Talamini, R., Polesel, J., Kendall, C. W. C., Jenkins, D. J. A., Vidgen, E., & Vecchia, C. L. (2004) · Oncology · doi:10.1159/000081322 · Cited by 35
Combination gonadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenism
Elkind-Hirsch, K. E., Anania, C. A., Mack, M., & Malinak, L. R. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57532-3 · Cited by 35
Hyperinsulinemia in the polycystic ovary syndrome: a clinical, endocrine and echographic study in 240 patients
Falsetti, L., & Eleftheriou, G. (1996) · Gynecological Endocrinology · doi:10.3109/09513599609012818 · Cited by 35
Diagnostic and therapeutic use of oral micronized progesterone in endocrinology
Memi, E., Pavli, P., Papagianni, M., Vrachnis, N., & Mastorakos, G. P. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09882-0 · Cited by 39
Caffeinated Coffee, Decaffeinated Coffee and Endometrial Cancer Risk: A Prospective Cohort Study among US Postmenopausal Women
Giri, A., Sturgeon, S. R., Luisi, N., Bertone‐Johnson, E. R., Balasubramanian, R., & Reeves, K. W. (2011) · Nutrients · doi:10.3390/nu3110937 · Cited by 34
The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta‐analysis
Barba, M., Schünemann, H. J., Sperati, F., Akl, E. A., Musicco, F., Guyatt, G. H., & Muti, P. C. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03459.x · Cited by 34
Racial difference in circulating sex hormone–binding globulin levels in prepubertal boys
Abdelrahaman, E., Raghavan, S., Baker, L., Weinrich, M. C., & Winters, S. J. (2004) · Metabolism · doi:10.1016/j.metabol.2004.07.018 · Cited by 34
Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome
Gagnon, C., & Baillargeon, J.-P. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060607 · Cited by 33
Clustering of metabolic and cardiovascular risk factors in the polycystic ovary syndrome: a principal component analysis
Stuckey, B. G. A., Opie, N., Cussons, A. J., Watts, G. F., & Burke, V. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.004 · Cited by 33
Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
Bloomgarden, Z. T., Futterweit, W., & Poretsky, L. (2001) · Endocrine Practice · doi:10.4158/ep.7.4.279 · Cited by 33
Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?
Cheang, K. I., & Nestler, J. E. (2004) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60928-5 · Cited by 33
Self-citation
The Biological Variation of Insulin Resistance in Polycystic Ovarian Syndrome
Jayagopal, V., Kilpatrick, E. S., Holding, S., Jennings, P. E., & Atkin, S. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8404 · Cited by 33
Mild Insulin Resistance during Oral Glucose Tolerance Test (OGTT) in Women with Acne
Aizawa, H., & Niimura, M. (1996) · The Journal of Dermatology · doi:10.1111/j.1346-8138.1996.tb02645.x · Cited by 33
The influence of luteinizing hormone and insulin on sex steroids and sex hormone-binding globulin in the polycystic ovarian syndrome
Buyalos, R. P., Geffner, M. E., Watanabe, R. M., Bergman, R. N., GORNBEIN, J. A., & Judd, H. L. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56212-8 · Cited by 33
Metformin Effects on Clinical Features, Endocrine and Metabolic Profiles, and Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled 6-Month Trial, followed by Open, Long-Term Clinical Evaluation1
Moghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., Zanolin, E., & Muggeo, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6293 · Cited by 660
Obesity and Postmenopausal Hormone Receptor-positive Breast Cancer: Epidemiology and Mechanisms
Zuo, Q., Band, S., Kesavadas, M. P., & Madak‐Erdogan, Z. (2021) · Endocrinology · doi:10.1210/endocr/bqab195 · Cited by 32
Sex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome.
Chen, C., Smothers, J., Lange, A., Nestler, J. E., Strauss, J. F., & Wickham, E. P. (2010) · PubMed · Cited by 32
Self-citation
The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome
Noyan, V., Yücel, A., & Sağsöz, N. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.01.031 · Cited by 32
Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?
Cheang, K. I., Sharma, S. T., & Nestler, J. E. (2006) · Gynecological Endocrinology · doi:10.1080/09513590601005847 · Cited by 32
Self-citation
A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome
Legro, R. S. (2007) · JAMA · doi:10.1001/jama.297.5.509 · Cited by 33
The effect of clomiphene citrate, herbal mixture, and herbal mixture along with clomiphene citrate on clinical and para-clinical parameters in infertile women with polycystic ovary syndrome: a randomized controlled clinical trial
Ainehchi, N., Khaki, A., Ouladsahebmadarek, E., Hammadeh, M., Farzadi, L., Farshbaf-Khalili, A., Asnaashari, S., Khamnei, H., Khaki, A. A., & Shokoohi, M. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.93271 · Cited by 31
Common Variants in the Sex Hormone-Binding Globulin (SHBG) Gene Influence SHBG Levels in Women with Polycystic Ovary Syndrome
Abu‐Hijleh, T. M., Gammoh, E., Al-Busaidi, A. S., Malalla, Z. H. A., Madan, S., Mahmood, N., & Almawi, W. Y. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000441570 · Cited by 31
Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients
Karadağ, C., Yoldemir, T., & Yavuz, D. G. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1250256 · Cited by 31
Anti-Müllerian Hormone as a Diagnostic Marker in Egyptian Infertile Polycystic Ovary Syndrome Females: Correlations with Vitamin D, Total Testosterone, Dyslipidemia and Anthropometric Parameters
Bakeer, E. M., Radwan, R. A., El-Mandoury, A. A.-A., Rahman, A. A. A. E., Gad, M. Z., & Maksoud, S. A. (2018) · Journal of Medical Biochemistry · doi:10.1515/jomb-2017-0068 · Cited by 31
Serum Androgens Are Independent Predictors of Insulin Clearance but Not of Insulin Secretion in Women With PCOS
Tosi, F., Molin, F. D., Zamboni, F., Saggiorato, E., Salvagno, G. L., Fiers, T., Kaufman, J., Bonora, E., & Moghetti, P. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa095 · Cited by 31
HMG-CoA Reductase Inhibitors
Kodaman, P. H., & Dulęba, A. J. (2008) · Drugs · doi:10.2165/00003495-200868130-00001 · Cited by 31
Ovarian Morphology by Transabdominal Ultrasound Correlates With Reproductive and Metabolic Disturbance in Adolescents With PCOS
Rackow, B. W., Brink, H. V., Hammers, L. W., Flannery, C. A., Lujan, M. E., & Burgert, T. S. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2017.09.005 · Cited by 31
Endocrine–metabolic effects of the treatment with pioglitazonein obese patients with polycystic ovary syndrome
Garmes, H. M., Tambascia, M. A., & Zantut‐Wittmann, D. E. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500430575 · Cited by 31
Metformin and Polycystic Ovary Syndrome: A Literature Review
Awartani, K. A., & Cheung, A. P. (2002) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30402-9 · Cited by 31
Association of dietary factors and selected plasma variables with sex hormone-binding globulin in rural Chinese women
Gates, J., Parpia, B., Campbell, T. C., & Junshi, C. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.1.22 · Cited by 30
Obesity and the Risk of Infertility, Gestational Diabetes, and Type 2 Diabetes in Polycystic Ovary Syndrome
Pirotta, S., Joham, A., Grieger, J. A., Tay, C. T., Bahri-Khomami, M., Lujan, M., Lim, S. S., & Moran, L. J. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1726866 · Cited by 29
Meibomian Gland Alterations in Polycystic Ovary Syndrome
Yavaş, G. F., Öztürk, F., Küsbeci, T., Ermiş, S. S., Yılmazer, M., Çevrioğlu, S., Aktepe, F., & Köse, S. (2008) · Current Eye Research · doi:10.1080/02713680701858410 · Cited by 29
The Effect of Raloxifene on Glyco-Insulinemic Homeostasis in Healthy Postmenopausal Women: A Randomized Placebo-Controlled Study
Cucinelli, F., Soranna, L., Romualdi, D., Muzj, G., Mancuso, S., & Lanzone, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011302 · Cited by 29
The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1
Pakarinen, P. I., Lähteenmäki, P., & Rutanen, E. (1999) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/j.1600-0412.1999.780515.x · Cited by 29
Role of sex steroids, intrahepatic fat and liver enzymes in the association between SHBG and metabolic features
Bonnet, F., Velayoudom Cephise, F., Gautier, A., Dubois, S., Massart, C., Camara, A., Larifla, L., Balkau, B., & Ducluzeau, P. (2013) · Clinical Endocrinology · doi:10.1111/cen.12089 · Cited by 28
Cryptotanshinone alleviates polycystic ovary syndrome in rats by regulating the HMGB1/TLR4/NF‑κB signaling pathway
Yang, Y., Yang, L., Qi, C., Hu, G., Wang, L., Sun, Z., & Ni, X. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11469 · Cited by 28
Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome
Koiou, E., Τζιόμαλος, Κ., Katsikis, I., Kandaraki, E., Kalaitzakis, E., Delkos, D., Vosnakis, C., & Panidis, D. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.588745 · Cited by 28
Clinical Evidence for Predominance of Delta-5 Steroid Production in Women with Polycystic Ovary Syndrome
Rosencrantz, M. A., Coffler, M. S., Haggan, A., Duke, K. B., Donohue, M., Shayya, R. F., Su, H.-C. I., & Chang, R. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2200 · Cited by 28
Polycystic Ovary Syndrome in Adolescence
Baumann, E. E., & Rosenfield, R. L. (2002) · The Endocrinologist · doi:10.1097/00019616-200207000-00011 · Cited by 28
Metabolic Lessons from the Study of Young Adolescents with Polycystic Ovary Syndrome--Is Insulin, Indeed, the Culprit?
Oberfield, S. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6959 · Cited by 28
Insulin Resistance at the Crossroads of Metabolic Inflammation, Cardiovascular Disease, Organ Failure and Cancer
Lonardo, A., & Weiskirchen, R. (2025) · Biomolecules · doi:10.3390/biom15121745 · Cited by 33
Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome
Lai, Y., Chen, J., Li, L., Jingxia, Y., He, J., Yang, M., Jia, Y., Liu, D., Liu, H., Liao, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep25934 · Cited by 26
The relationship between Vitamin D deficiency and polycystic ovary syndrome
Gökosmanoğlu, F., Önmez, A., & Ergenç, H. (2020) · African Health Sciences · doi:10.4314/ahs.v20i4.45 · Cited by 27
Alcohol intake and endometrial cancer risk: a meta-analysis of prospective studies
Friberg, E., Orsini, N., Mantzoros, C. S., & Wolk, A. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605698 · Cited by 27
Optimal management of polycystic ovary syndrome in adolescence
Baldauff, N. H., & Arslanian, S. A. (2015) · Archives of Disease in Childhood · doi:10.1136/archdischild-2014-306471 · Cited by 27
The effect of metformin treatment to ovarian response in cases with PCOS
Taşdemir, S., Fıçıcıoğlu, C., Yaltı, S., Gürbüz, B., Başaran, T., & Yıldırım, G. (2003) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-002-0447-8 · Cited by 27
The Link between Polycystic Ovary Syndrome and both Type 1 and Type 2 Diabetes Mellitus: What Do we Know Today?
Barber, T. M., & Franks, S. (2012) · Women s Health · doi:10.2217/whe.11.94 · Cited by 26
Serum visfatin levels in non-obese women with polycystic ovary syndrome and matched controls
Kim, J., Choi, Y. M., Hong, M. A., Kim, M.-J., Chae, S. J., Kim, S. M., Hwang, K. R., Yoon, S. H., Ku, S., Suh, C. S., et al. (2018) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2018.61.2.253 · Cited by 26
The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study
Panidis, D., Τζιόμαλος, Κ., Koiou, E., Kandaraki, E., Tsourdi, E. A., Delkos, D., Kalaitzakis, E., & Katsikis, I. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-151 · Cited by 26
An in vivo murine model of rosiglitazone use in pregnancy
Klinkner, D. B., Lim, H. J., Strawn, E., Oldham, K. T., & Sander, T. L. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.024 · Cited by 26
Anti-androgens for the treatment of hirsutism
Carmina, E. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.3.357 · Cited by 26
Clustering of Cardiovascular Risk Factors Associated With the Insulin Resistance Syndrome
Zanolin, M. E., Tosi, F., Zoppini, G., Castello, R., Spiazzi, G., Dorizzi, R. M., Muggeo, M., & Moghetti, P. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1478 · Cited by 25
Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome
Papaetis, G. S., Filippou, P. K., Constantinidou, K. G., & Stylianou, C. S. (2020) · Clinical Drug Investigation · doi:10.1007/s40261-020-00942-2 · Cited by 25
Increased Total Renin Levels but Not Angiotensin-Converting Enzyme Activity in Obese Patients with Polycystic Ovary Syndrome
Üç, Z. A., Berberoğlu, Z., Görar, S., Candan, Z., Aktas, A., Aral, Y., & Ademoglu, E. N. (2013) · Medical Principles and Practice · doi:10.1159/000351572 · Cited by 25
Inositolphosphoglycans (IPGs) as Mediators of Insulin's Steroidogenic Actions
Nestler, J. E. (1998) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.1998.9.2-4.197 · Cited by 25
Self-citation
Treatment of the Infertile Patient With Polycystic Ovarian Syndrome
Pritts, E. A. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200209000-00022 · Cited by 25
The Polycystic Ovary Syndrome: Current Concepts On Pathogenesis And Clinical Care
Azziz, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7 · Cited by 25
The Predictive Power of Endocrine Tests for the Diagnosis of Polycystic Ovaries in Women with Oligoamenorrhea
Turhan, N. Ö., Toppare, M. F., Seçkin, N. C., & Dilmen, G. (1999) · Gynecologic and Obstetric Investigation · doi:10.1159/000010170 · Cited by 25
Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome
Al-Zubeidi, H., & Klein, K. O. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0283 · Cited by 24

Authors: NESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G.
Affiliations: Madigan Army Medical Center (US)
ORCID: PLYMATE, STEPHEN R.
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 1991-01
Volume: 72
Issue: 1
Pages: 83-89
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jcem-72-1-83
OpenAlex: W2008509267
Cited by: 815
References: 38
Citations by year: 2026: 13 · 2025: 22 · 2024: 25 · 2023: 25 · 2022: 28 · 2021: 38 · 2020: 27 · 2019: 25 · 2018: 18 · 2017: 25 · 2016: 25 · 2015: 30 · 2014: 22 · 2013: 27 · 2012: 18
FWCI: 10.34
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Diabetes and Digestive and Kidney Diseases (DK-18904)
National Center for Research Resources (RR 00065, M01RR000065)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: hyperinsulinemia, sex hormone-binding globulin, polycystic ovary syndrome, obesity, insulin resistance, diazoxide, leuprolide, GnRH agonist, testosterone, androstenedione, estradiol, estrone, glucose tolerance, insulin secretion, ovarian steroidogenesis, glucose-insulin interaction, insulin sensitivity index, insulin resistance index
MeSH terms: Adult, Androstenedione, Diazoxide, Estradiol, Estrone, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Gonadotropin-Releasing Hormone, Obesity, Polycystic Ovary Syndrome, Progesterone, Sex Hormone-Binding Globulin, Testosterone, Androstane-3,17-diol, Leuprolide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Direct Effect of Hyperinsulinemia on Serum Sex Hormone-Binding Globulin Levels in Obese Women with the Polycystic Ovary Syndrome*

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks